A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons
Introduction Several medication classes are considered to present risk factors for falls. However, the evidence is mainly based on observational studies that often lack adequate adjustment for confounders. Therefore, we aimed to assess the associations of medication classes with fall risk by careful...
Gespeichert in:
Veröffentlicht in: | Drugs & aging 2021-09, Vol.38 (9), p.797-805 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 805 |
---|---|
container_issue | 9 |
container_start_page | 797 |
container_title | Drugs & aging |
container_volume | 38 |
creator | Seppala, L. J. van de Loo, B. Schut, M. van Schoor, N. M. Stricker, B. H. Kenny, R. A. Moriarty, F. de Groot, L. C. P. G. M. Denkinger, M. Rothenbacher, D. van der Velde, Nathalie Abu-Hanna, A. |
description | Introduction
Several medication classes are considered to present risk factors for falls. However, the evidence is mainly based on observational studies that often lack adequate adjustment for confounders. Therefore, we aimed to assess the associations of medication classes with fall risk by carefully selecting confounders and by applying propensity score matching (PSM).
Methods
Data from several European cohorts, harmonized into the AD
F
ICE_IT cohort, was used. Our primary outcome was time until the first fall within 1-year follow-up. The secondary outcome was a fall in the past year. Our exposure variables were commonly prescribed medications. We used 1:1 PSM to match the participants with reported intake of specific medication classes with participants without. We constructed Cox regression models stratified by the pairs matched on the propensity score for our primary outcome and conditional logistic regression models for our secondary outcome.
Results
In total, 32.6% of participants fell in the 1-year follow-up and 24.4% reported falling in the past year. ACE inhibitor users (prevalence of use 15.3%) had a lower fall risk during follow-up when matched to non-users, with a hazard ratio (HR) of 0.82 (95% CI 0.68–0.98). Also, statin users (prevalence of use 20.1%) had a lower risk, with an HR of 0.76 (95% CI 0.65–0.90). Other medication classes showed no association with risk of first fall. Also, in our secondary outcome analyses, statin users had a significantly lower risk. Furthermore, β-blocker users had a lower fall risk and proton pump inhibitor use was associated with a higher risk in our secondary outcome analysis.
Conclusion
Many commonly prescribed medication classes showed no associations with fall risk in a relatively healthy population of community-dwelling older persons. However, the treatment effects and risks can be heterogeneous between individuals. Therefore, focusing on identification of individuals at risk is warranted to optimize personalized falls prevention. |
doi_str_mv | 10.1007/s40266-021-00876-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8419131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2548607364</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-65e160e375db49535edecccd993f3a9421b850a54f87620d9247c43162562f593</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEoqXwAiyQJTZsAr5nvEGKRpQiTVXERWJnOc7JxCWJg-2AhjfiLfF0hnJZsPKR_P2ffexTFI8Jfk4wrl5EjqmUJaakxHhV5epOcUpIpUqipLp7U-OSUvXppHgQ4zXGWFJK7hcnjFPKCeanxY8avQ1-him6tEPvrQ-ALk2yPbSonufgje1R8qiOEWJEqYd96a0zyfkpIt-htR9HPw27LIJog2ty9BJaZ4_IN5d6dG6GAb1z8TNyEzJoY8IW0IUJOem-58Da9z6kve5qaCGgemyWwSQfshZCzJ6Hxb3ODBEeHdez4uP5qw_ri3Jz9frNut6Ullc8lVIAkRhYJdqGK8EEtGCtbZViHTOKU9KsBDaCd_nFKG4V5ZXljEgqJO2EYmfFy4N3XpoRWgtTCmbQc3CjCTvtjdN_70yu11v_Va84UYSRLHh2FAT_ZYGY9OiihWEwE_glair4SuKKSZ7Rp_-g134JU24vUxXhilGMM0UPlA0-xgDd7WUI1vtJ0IdJ0HkS9M0k6H3oyZ9t3EZ-fX0G2AGIeWvaQvh99n-0PwEw_cC4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2571493200</pqid></control><display><type>article</type><title>A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Seppala, L. J. ; van de Loo, B. ; Schut, M. ; van Schoor, N. M. ; Stricker, B. H. ; Kenny, R. A. ; Moriarty, F. ; de Groot, L. C. P. G. M. ; Denkinger, M. ; Rothenbacher, D. ; van der Velde, Nathalie ; Abu-Hanna, A.</creator><creatorcontrib>Seppala, L. J. ; van de Loo, B. ; Schut, M. ; van Schoor, N. M. ; Stricker, B. H. ; Kenny, R. A. ; Moriarty, F. ; de Groot, L. C. P. G. M. ; Denkinger, M. ; Rothenbacher, D. ; van der Velde, Nathalie ; Abu-Hanna, A.</creatorcontrib><description>Introduction
Several medication classes are considered to present risk factors for falls. However, the evidence is mainly based on observational studies that often lack adequate adjustment for confounders. Therefore, we aimed to assess the associations of medication classes with fall risk by carefully selecting confounders and by applying propensity score matching (PSM).
Methods
Data from several European cohorts, harmonized into the AD
F
ICE_IT cohort, was used. Our primary outcome was time until the first fall within 1-year follow-up. The secondary outcome was a fall in the past year. Our exposure variables were commonly prescribed medications. We used 1:1 PSM to match the participants with reported intake of specific medication classes with participants without. We constructed Cox regression models stratified by the pairs matched on the propensity score for our primary outcome and conditional logistic regression models for our secondary outcome.
Results
In total, 32.6% of participants fell in the 1-year follow-up and 24.4% reported falling in the past year. ACE inhibitor users (prevalence of use 15.3%) had a lower fall risk during follow-up when matched to non-users, with a hazard ratio (HR) of 0.82 (95% CI 0.68–0.98). Also, statin users (prevalence of use 20.1%) had a lower risk, with an HR of 0.76 (95% CI 0.65–0.90). Other medication classes showed no association with risk of first fall. Also, in our secondary outcome analyses, statin users had a significantly lower risk. Furthermore, β-blocker users had a lower fall risk and proton pump inhibitor use was associated with a higher risk in our secondary outcome analysis.
Conclusion
Many commonly prescribed medication classes showed no associations with fall risk in a relatively healthy population of community-dwelling older persons. However, the treatment effects and risks can be heterogeneous between individuals. Therefore, focusing on identification of individuals at risk is warranted to optimize personalized falls prevention.</description><identifier>ISSN: 1170-229X</identifier><identifier>EISSN: 1179-1969</identifier><identifier>DOI: 10.1007/s40266-021-00876-0</identifier><identifier>PMID: 34224104</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Accidental Falls - prevention & control ; Adjustment ; Aged ; Aged, 80 and over ; Cohort Studies ; Drug withdrawal ; Falls ; Geriatrics/Gerontology ; Health risks ; Humans ; Independent Living ; Injury prevention ; Internal Medicine ; Medicine ; Medicine & Public Health ; Older people ; Original ; Original Research Article ; Pharmacology/Toxicology ; Pharmacotherapy ; Polypharmacy ; Propensity Score ; Quality of life ; Risk Factors</subject><ispartof>Drugs & aging, 2021-09, Vol.38 (9), p.797-805</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>Copyright Springer Nature B.V. Sep 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-65e160e375db49535edecccd993f3a9421b850a54f87620d9247c43162562f593</citedby><cites>FETCH-LOGICAL-c474t-65e160e375db49535edecccd993f3a9421b850a54f87620d9247c43162562f593</cites><orcidid>0000-0002-6477-6209</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40266-021-00876-0$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40266-021-00876-0$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34224104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seppala, L. J.</creatorcontrib><creatorcontrib>van de Loo, B.</creatorcontrib><creatorcontrib>Schut, M.</creatorcontrib><creatorcontrib>van Schoor, N. M.</creatorcontrib><creatorcontrib>Stricker, B. H.</creatorcontrib><creatorcontrib>Kenny, R. A.</creatorcontrib><creatorcontrib>Moriarty, F.</creatorcontrib><creatorcontrib>de Groot, L. C. P. G. M.</creatorcontrib><creatorcontrib>Denkinger, M.</creatorcontrib><creatorcontrib>Rothenbacher, D.</creatorcontrib><creatorcontrib>van der Velde, Nathalie</creatorcontrib><creatorcontrib>Abu-Hanna, A.</creatorcontrib><title>A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons</title><title>Drugs & aging</title><addtitle>Drugs Aging</addtitle><addtitle>Drugs Aging</addtitle><description>Introduction
Several medication classes are considered to present risk factors for falls. However, the evidence is mainly based on observational studies that often lack adequate adjustment for confounders. Therefore, we aimed to assess the associations of medication classes with fall risk by carefully selecting confounders and by applying propensity score matching (PSM).
Methods
Data from several European cohorts, harmonized into the AD
F
ICE_IT cohort, was used. Our primary outcome was time until the first fall within 1-year follow-up. The secondary outcome was a fall in the past year. Our exposure variables were commonly prescribed medications. We used 1:1 PSM to match the participants with reported intake of specific medication classes with participants without. We constructed Cox regression models stratified by the pairs matched on the propensity score for our primary outcome and conditional logistic regression models for our secondary outcome.
Results
In total, 32.6% of participants fell in the 1-year follow-up and 24.4% reported falling in the past year. ACE inhibitor users (prevalence of use 15.3%) had a lower fall risk during follow-up when matched to non-users, with a hazard ratio (HR) of 0.82 (95% CI 0.68–0.98). Also, statin users (prevalence of use 20.1%) had a lower risk, with an HR of 0.76 (95% CI 0.65–0.90). Other medication classes showed no association with risk of first fall. Also, in our secondary outcome analyses, statin users had a significantly lower risk. Furthermore, β-blocker users had a lower fall risk and proton pump inhibitor use was associated with a higher risk in our secondary outcome analysis.
Conclusion
Many commonly prescribed medication classes showed no associations with fall risk in a relatively healthy population of community-dwelling older persons. However, the treatment effects and risks can be heterogeneous between individuals. Therefore, focusing on identification of individuals at risk is warranted to optimize personalized falls prevention.</description><subject>Accidental Falls - prevention & control</subject><subject>Adjustment</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cohort Studies</subject><subject>Drug withdrawal</subject><subject>Falls</subject><subject>Geriatrics/Gerontology</subject><subject>Health risks</subject><subject>Humans</subject><subject>Independent Living</subject><subject>Injury prevention</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Older people</subject><subject>Original</subject><subject>Original Research Article</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Polypharmacy</subject><subject>Propensity Score</subject><subject>Quality of life</subject><subject>Risk Factors</subject><issn>1170-229X</issn><issn>1179-1969</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kstu1DAUhiMEoqXwAiyQJTZsAr5nvEGKRpQiTVXERWJnOc7JxCWJg-2AhjfiLfF0hnJZsPKR_P2ffexTFI8Jfk4wrl5EjqmUJaakxHhV5epOcUpIpUqipLp7U-OSUvXppHgQ4zXGWFJK7hcnjFPKCeanxY8avQ1-him6tEPvrQ-ALk2yPbSonufgje1R8qiOEWJEqYd96a0zyfkpIt-htR9HPw27LIJog2ty9BJaZ4_IN5d6dG6GAb1z8TNyEzJoY8IW0IUJOem-58Da9z6kve5qaCGgemyWwSQfshZCzJ6Hxb3ODBEeHdez4uP5qw_ri3Jz9frNut6Ullc8lVIAkRhYJdqGK8EEtGCtbZViHTOKU9KsBDaCd_nFKG4V5ZXljEgqJO2EYmfFy4N3XpoRWgtTCmbQc3CjCTvtjdN_70yu11v_Va84UYSRLHh2FAT_ZYGY9OiihWEwE_glair4SuKKSZ7Rp_-g134JU24vUxXhilGMM0UPlA0-xgDd7WUI1vtJ0IdJ0HkS9M0k6H3oyZ9t3EZ-fX0G2AGIeWvaQvh99n-0PwEw_cC4</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Seppala, L. J.</creator><creator>van de Loo, B.</creator><creator>Schut, M.</creator><creator>van Schoor, N. M.</creator><creator>Stricker, B. H.</creator><creator>Kenny, R. A.</creator><creator>Moriarty, F.</creator><creator>de Groot, L. C. P. G. M.</creator><creator>Denkinger, M.</creator><creator>Rothenbacher, D.</creator><creator>van der Velde, Nathalie</creator><creator>Abu-Hanna, A.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6477-6209</orcidid></search><sort><creationdate>20210901</creationdate><title>A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons</title><author>Seppala, L. J. ; van de Loo, B. ; Schut, M. ; van Schoor, N. M. ; Stricker, B. H. ; Kenny, R. A. ; Moriarty, F. ; de Groot, L. C. P. G. M. ; Denkinger, M. ; Rothenbacher, D. ; van der Velde, Nathalie ; Abu-Hanna, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-65e160e375db49535edecccd993f3a9421b850a54f87620d9247c43162562f593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Accidental Falls - prevention & control</topic><topic>Adjustment</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cohort Studies</topic><topic>Drug withdrawal</topic><topic>Falls</topic><topic>Geriatrics/Gerontology</topic><topic>Health risks</topic><topic>Humans</topic><topic>Independent Living</topic><topic>Injury prevention</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Older people</topic><topic>Original</topic><topic>Original Research Article</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Polypharmacy</topic><topic>Propensity Score</topic><topic>Quality of life</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seppala, L. J.</creatorcontrib><creatorcontrib>van de Loo, B.</creatorcontrib><creatorcontrib>Schut, M.</creatorcontrib><creatorcontrib>van Schoor, N. M.</creatorcontrib><creatorcontrib>Stricker, B. H.</creatorcontrib><creatorcontrib>Kenny, R. A.</creatorcontrib><creatorcontrib>Moriarty, F.</creatorcontrib><creatorcontrib>de Groot, L. C. P. G. M.</creatorcontrib><creatorcontrib>Denkinger, M.</creatorcontrib><creatorcontrib>Rothenbacher, D.</creatorcontrib><creatorcontrib>van der Velde, Nathalie</creatorcontrib><creatorcontrib>Abu-Hanna, A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Drugs & aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seppala, L. J.</au><au>van de Loo, B.</au><au>Schut, M.</au><au>van Schoor, N. M.</au><au>Stricker, B. H.</au><au>Kenny, R. A.</au><au>Moriarty, F.</au><au>de Groot, L. C. P. G. M.</au><au>Denkinger, M.</au><au>Rothenbacher, D.</au><au>van der Velde, Nathalie</au><au>Abu-Hanna, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons</atitle><jtitle>Drugs & aging</jtitle><stitle>Drugs Aging</stitle><addtitle>Drugs Aging</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>38</volume><issue>9</issue><spage>797</spage><epage>805</epage><pages>797-805</pages><issn>1170-229X</issn><eissn>1179-1969</eissn><abstract>Introduction
Several medication classes are considered to present risk factors for falls. However, the evidence is mainly based on observational studies that often lack adequate adjustment for confounders. Therefore, we aimed to assess the associations of medication classes with fall risk by carefully selecting confounders and by applying propensity score matching (PSM).
Methods
Data from several European cohorts, harmonized into the AD
F
ICE_IT cohort, was used. Our primary outcome was time until the first fall within 1-year follow-up. The secondary outcome was a fall in the past year. Our exposure variables were commonly prescribed medications. We used 1:1 PSM to match the participants with reported intake of specific medication classes with participants without. We constructed Cox regression models stratified by the pairs matched on the propensity score for our primary outcome and conditional logistic regression models for our secondary outcome.
Results
In total, 32.6% of participants fell in the 1-year follow-up and 24.4% reported falling in the past year. ACE inhibitor users (prevalence of use 15.3%) had a lower fall risk during follow-up when matched to non-users, with a hazard ratio (HR) of 0.82 (95% CI 0.68–0.98). Also, statin users (prevalence of use 20.1%) had a lower risk, with an HR of 0.76 (95% CI 0.65–0.90). Other medication classes showed no association with risk of first fall. Also, in our secondary outcome analyses, statin users had a significantly lower risk. Furthermore, β-blocker users had a lower fall risk and proton pump inhibitor use was associated with a higher risk in our secondary outcome analysis.
Conclusion
Many commonly prescribed medication classes showed no associations with fall risk in a relatively healthy population of community-dwelling older persons. However, the treatment effects and risks can be heterogeneous between individuals. Therefore, focusing on identification of individuals at risk is warranted to optimize personalized falls prevention.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>34224104</pmid><doi>10.1007/s40266-021-00876-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-6477-6209</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1170-229X |
ispartof | Drugs & aging, 2021-09, Vol.38 (9), p.797-805 |
issn | 1170-229X 1179-1969 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8419131 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Accidental Falls - prevention & control Adjustment Aged Aged, 80 and over Cohort Studies Drug withdrawal Falls Geriatrics/Gerontology Health risks Humans Independent Living Injury prevention Internal Medicine Medicine Medicine & Public Health Older people Original Original Research Article Pharmacology/Toxicology Pharmacotherapy Polypharmacy Propensity Score Quality of life Risk Factors |
title | A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A19%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Propensity%20Score%20Matched%20Approach%20to%20Assess%20the%20Associations%20of%20Commonly%20Prescribed%20Medications%20with%20Fall%20Risk%20in%20a%20Large%20Harmonized%20Cohort%20of%20Older%20Ambulatory%20Persons&rft.jtitle=Drugs%20&%20aging&rft.au=Seppala,%20L.%20J.&rft.date=2021-09-01&rft.volume=38&rft.issue=9&rft.spage=797&rft.epage=805&rft.pages=797-805&rft.issn=1170-229X&rft.eissn=1179-1969&rft_id=info:doi/10.1007/s40266-021-00876-0&rft_dat=%3Cproquest_pubme%3E2548607364%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2571493200&rft_id=info:pmid/34224104&rfr_iscdi=true |